Lipoxin A4modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lipoxin A4modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 44, Issue 2, Pages 357-369
Publisher
Wiley
Online
2013-10-25
DOI
10.1002/eji.201343316
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resolvin E1 Metabolome in Local Inactivation during Inflammation-Resolution
- (2014) S. Hong et al. JOURNAL OF IMMUNOLOGY
- Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Potent Immunoresolvents
- (2013) Jesmond Dalli et al. CHEMISTRY & BIOLOGY
- Novel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors
- (2012) Charles N. Serhan et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Characterization of the Promoter and the Transcriptional Regulation of the Lipoxin A4 Receptor (FPR2/ALX) Gene in Human Monocytes and Macrophages
- (2012) V. Waechter et al. JOURNAL OF IMMUNOLOGY
- Specialized Proresolving Mediators Enhance Human B Cell Differentiation to Antibody-Secreting Cells
- (2012) S. Ramon et al. JOURNAL OF IMMUNOLOGY
- Resolvins and Protectins in Inflammation Resolution
- (2011) Charles N. Serhan et al. CHEMICAL REVIEWS
- Lipoxygenase and Leukotriene Pathways: Biochemistry, Biology, and Roles in Disease
- (2011) Jesper Z. Haeggström et al. CHEMICAL REVIEWS
- Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity
- (2011) Felice Simiele et al. FASEB JOURNAL
- Resolvin D1 protects mice from LPS-induced acute lung injury
- (2011) Bin Wang et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Memory B cells from older people express normal levels of cyclooxygenase-2 and produce higher levels of IL-6 and IL-10 upon in vitro activation
- (2010) Simona Bancos et al. CELLULAR IMMUNOLOGY
- Changes in circuIating B cells and immunoglobulin cIasses and subcIasses in a healthy aged popuIation
- (2010) R. PAGANELLI et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Anti-Inflammatory Role of the Murine Formyl-Peptide Receptor 2: Ligand-Specific Effects on Leukocyte Responses and Experimental Inflammation
- (2010) Neil Dufton et al. JOURNAL OF IMMUNOLOGY
- Resolvin D1 binds human phagocytes with evidence for proresolving receptors
- (2010) S. Krishnamoorthy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human B cell memory
- (2009) Antonio Lanzavecchia et al. CURRENT OPINION IN IMMUNOLOGY
- International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
- (2009) R. D. Ye et al. PHARMACOLOGICAL REVIEWS
- New insights into the regulation of human B-cell differentiation
- (2009) Heike Schmidlin et al. TRENDS IN IMMUNOLOGY
- Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake
- (2008) Raewyn C. Poulsen et al. AMERICAN JOURNAL OF HEMATOLOGY
- Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets
- (2008) M. Dona et al. BLOOD
- Peroxisome Proliferator-Activated Receptor Overexpression Suppresses Growth and Induces Apoptosis in Human Multiple Myeloma Cells
- (2008) T. M. Garcia-Bates et al. CLINICAL CANCER RESEARCH
- BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis
- (2008) L. Zhang et al. INFLAMMATION RESEARCH
- Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2and LXA4in the induction of macrophage death
- (2008) Minjian Chen et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started